BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 26164481)

  • 1. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis.
    Alsan M; Schoemaker L; Eggleston K; Kammili N; Kolli P; Bhattacharya J
    Lancet Infect Dis; 2015 Oct; 15(10):1203-1210. PubMed ID: 26164481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2019 Jun; 393(10187):2233-2260. PubMed ID: 31030984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2017 May; 389(10083):2005-2030. PubMed ID: 28433260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
    Versporten A; Zarb P; Caniaux I; Gros MF; Drapier N; Miller M; Jarlier V; Nathwani D; Goossens H;
    Lancet Glob Health; 2018 Jun; 6(6):e619-e629. PubMed ID: 29681513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating private sector out-of-pocket expenditures on family planning commodities in low-and-middle-income countries.
    Weinberger M; Bellows N; Stover J
    BMJ Glob Health; 2021 Apr; 6(4):. PubMed ID: 33846142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking total spending on tuberculosis by source and function in 135 low-income and middle-income countries, 2000-17: a financial modelling study.
    Su Y; Garcia Baena I; Harle AC; Crosby SW; Micah AE; Siroka A; Sahu M; Tsakalos G; Murray CJL; Floyd K; Dieleman JL
    Lancet Infect Dis; 2020 Aug; 20(8):929-942. PubMed ID: 32334658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out-of-pocket payments for complementary medicine following cancer and the effect on financial outcomes in middle-income countries in southeast Asia: a prospective cohort study.
    Kong YC; Kimman M; Subramaniam S; Yip CH; Jan S; Aung S; Khoa MT; Ngelangel CA; Nyein HL; Sangrajrang S; Tanabodee J; Bhoo-Pathy N;
    Lancet Glob Health; 2022 Mar; 10(3):e416-e428. PubMed ID: 35180423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bucking the trend? Health care expenditures in low-income countries 1990-1995.
    Jowett M
    Int J Health Plann Manage; 1999; 14(4):269-85. PubMed ID: 11184914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health insurance and the poor in low income countries.
    Grant K; Grant R
    World Hosp Health Serv; 2003; 39(1):19-22. PubMed ID: 12743884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic patterns in national health expenditure.
    Musgrove P; Zeramdini R; Carrin G
    Bull World Health Organ; 2002; 80(2):134-42. PubMed ID: 11953792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental health care and out-of-pocket expenditures in Europe: results from the ESEMeD project.
    Sevilla-Dedieu C; Kovess-Masfety V; Gilbert F; Vilagut G; Koenig HH; Bruffaerts R; Haro JM; Alonso J
    J Ment Health Policy Econ; 2011 Jun; 14(2):95-105. PubMed ID: 21881165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics, copayments, and antimicrobial resistance: investment matters.
    Fitchett JR
    Lancet Infect Dis; 2015 Oct; 15(10):1125-1127. PubMed ID: 26164480
    [No Abstract]   [Full Text] [Related]  

  • 14. National health expenditures: a global analysis.
    Murray CJ; Govindaraj R; Musgrove P
    Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in out-of-pocket health care expenditures in Canada, by household income, 1997 to 2009.
    Sanmartin C; Hennessy D; Lu Y; Law MR
    Health Rep; 2014 Apr; 25(4):13-7. PubMed ID: 24744043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and expenditure at public and private facilities in 39 low-income countries.
    Saksena P; Xu K; Elovainio R; Perrot J
    Trop Med Int Health; 2012 Jan; 17(1):23-35. PubMed ID: 22008480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policy and priorities for national cancer control planning in low- and middle-income countries: Lessons from the Association of Southeast Asian Nations (ASEAN) Costs in Oncology prospective cohort study.
    ACTION Study Group
    Eur J Cancer; 2017 Mar; 74():26-37. PubMed ID: 28335885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis.
    Lee JT; Hamid F; Pati S; Atun R; Millett C
    PLoS One; 2015; 10(7):e0127199. PubMed ID: 26154083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.